Meds A-Z
Polymyxin B
Detailed information about Polymyxin B
Pet Owner Quick Guide
Start here: what this medicine is for, what it does, and when it's usually needed.
Usually used for:
Terramycin® is indicated for the prophylaxis and local treatment of superficial ocular infections due to oxytetracycline and polymyxin-sensitive organisms, including infections due to streptococci, rickettsiae, E. coli ,...
What it does:
Terramycin® is indicated for the prophylaxis and local treatment of superficial ocular infections due to oxytetracycline and polymyxin-sensitive organisms, including infections due to streptococci, rickettsiae, E. coli ,...
When it's needed:
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For use in dogs only. Shake drug thoroughly and clean lesion before using. If redness, irritation, or swelling persists or increases,...
Call your vet sooner if you notice:
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. For use in dogs only. Shake drug thoroughly and clean lesion before using. If redness, irritation, or swelling persists or increases, discontinue use and reevaluate diagnosis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Do not administer orally. Do not use in dogs with known perforated tympanum. Do not use with drugs known to induce ototoxicity. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Commonly reported reactions:
- (2 reports)
- (2 reports)
- (1 reports)
What to ask your vet today:
- Is this medicine the right fit for my pet’s current symptoms?
- Which warning signs mean I should call back right away?
- How should I handle missed doses or refusal to take the medicine?
Polymyxin B
Drug type: Generic ingredient • Branded profile • FDA branded products available
Species: Both
Manufacturer: Zoetis Inc.
Quick Facts
Official label facts first, then secondary summaries. Marketing content is separated below.
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/8763 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov/adafda/views/#/home/previewsearch/200553 · official_label · FDA application profile
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Medication usage source
Warnings / Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For use in dogs only. Shake drug thoroughly and clean lesion before using. If redness, irritation, or swelling persists or increases, discontinue use and reevaluate diagnosis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Do not administer orally. Do not use in dogs with known perforated tympanum. Do not use with drugs known to induce ototoxicity. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- High: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For use in dogs only. Shake drug thoroughly and clean lesion before using. If redness, irritation, or swelling persists or increases, discontinue use and reevaluate diagnosis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Do not administer orally. Do not use in dogs with known perforated tympanum. Do not use with drugs known to induce ototoxicity. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
- https://animaldrugsatfda.fda.gov · fda_animal_drugs · Contraindication source
Adverse Reactions
Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.
Tap or hover a reaction to see what it means in plain language.
Most Reported Reactions
| Reaction | Cases | Species | Serious cases |
|---|---|---|---|
| 2 | Cat, Dog | 2 | |
| 2 | Cat, Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 1 | |
| 1 | Dog | 1 | |
| 1 | Dog | 1 | |
| 1 | Cat | 0 | |
| 1 | Cat | 0 |
Species coverage: Cat (17) Dog (15)
View detailed reaction table
| Reaction | Species | Seriousness | Frequency | Reports |
|---|---|---|---|---|
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Cat | Non-serious | - | 1 | |
| Dog | Unknown | - | - | |
| Dog | Unknown | - | - | |
| Dog | Unknown | - | - | |
| Dog | Unknown | - | - | |
| Dog | Unknown | - | - | |
| Cat | Unknown | - | - | |
| Cat | Unknown | - | - |
- https://api.fda.gov/animalandveterinary/event.json · adverse_reaction · openFDA case USA-USFDACVM-2024-US-041625
Storage & Handling
No storage/handling guidance is linked yet.
Documents
Official label facts are separated from secondary summaries.
Official documents: 17 • Secondary summaries: 0
- Terramycin® · SPL
- UCM457307.pdf · FOI
- Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment · SPL
- Anaprime® Ophthalmic Solution · SPL
- Anaprime® Opthakote Ophthalmic · SPL
- Bac-Neo-Poly Ophthalmic Ointment · SPL
- Vetropolycin Ophthalmic Ointment · SPL
- Cortisporin Veterinary Ophthalmic Ointment · SPL
- Forte Topical® Ointment · SPL
- Mycitracin® Sterile Ophthalmic Ointment · SPL
- Neosporin Ophthalmic Ointment · SPL
- Optiprime® Opthakote Ophthalmic Solution · SPL
- UCM202424.pdf · FOI
- Surolan® · SPL
- Toptic Ointment (15 g) · SPL
- Vetropolycin HC Ophthalmic Ointment · SPL
- Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment · SPL
No source yet.
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/602/Terramycin%C2%AE · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/document/downloadFoi/1236 · document · FOI
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/2275/Neomycin%20and%20Polymyxin%20B%20Sulfates%2C%20and%20Bacitracin%20Zinc%20Ophthalmic%20Ointment · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/12/Anaprime%C2%AE%20Ophthalmic%20Solution · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/955/Anaprime%C2%AE%20Opthakote%20Ophthalmic · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/995/Bac-Neo-Poly%20Ophthalmic%20Ointment · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/996/Vetropolycin%20Ophthalmic%20Ointment · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1294/Cortisporin%20Veterinary%20Ophthalmic%20Ointment · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/961/Forte%20Topical%C2%AE%20Ointment · document · SPL
- https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/1080/Mycitracin%C2%AE%20Sterile%20Ophthalmic%20Ointment · document · SPL
Promotional Materials (Marketing)
This content is marketing material and not clinical guidance.
No marketing assets are linked yet.
No source yet.
Technical appendix (vet reference)
Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.
At a Glance
Quick facts and links to official labeling and safety signals.
- Medication catalog: Source PetWisePlus | Refreshed Feb 12, 2026, 10:44 PM UTC
-
Animal Drugs @ FDA:
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Applications/products are imported from FDA export data.
-
Animal Drugs @ FDA previews:
Source FDA
| Refreshed Feb 9, 2026, 3:05 AM UTC
Label highlights/doc links are fetched from FDA preview endpoints.
-
Animal Drug Product Listing Directory (NDC):
Source FDA
| Refreshed Feb 16, 2026, 11:00 AM UTC
Package/product NDCs from FDA’s electronic listing directory (XLS).
- openFDA reaction terms: Source FDA openFDA | Refreshed Feb 16, 2026, 11:04 AM UTC
- openFDA case summaries: Source FDA openFDA | Refreshed Feb 9, 2026, 3:22 AM UTC
Counseling and Monitoring Highlights
Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.
- Federal law restricts this drug to use by or on the order of a licensed veterinarian. For use in dogs only. Shake drug thoroughly and clean lesion before using. If redness, irritation, or swelling persists or increases, discontinue use and reevaluate diagnosis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Do not administer orally. Do not use in dogs with known perforated tympanum. Do not use with drugs known to induce ototoxicity. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (Contraindication, High)
Identifiers & Packages
Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.
| Package NDC | Product NDC | Form / Route | Status |
|---|---|---|---|
| 54771-1096-1 | 54771 | - | |
| 58198-0813-1 | 58198 | - | |
| 58198-0813-2 | 58198 | - | |
| 63732-2043-4 | 63732 | - |
Enriched Documents
Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.
-
UCM457307.pdf
• FOI summary • Official
• Oct. 25, 2023
FDA FOI summary for application 200553
-
UCM202424.pdf
• FOI summary • Official
• June 1, 2016
FDA FOI summary for application 141298
Data Sources & Revision History
Every non-trivial field is expected to include provenance and update timestamps.
- contraindications: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For use in dogs only. Shake drug thoroughly and clean lesion before using… (Official, 2026-02-12)
- side_effects: Top reported reactions (openFDA): Loss of hearing, Deafness, Lack of efficacy - NOS, Impaired hearing, Hearing decreased, Behavioural disorder NOS. (Official, 2026-02-12)
- usage: Terramycin® is indicated for the prophylaxis and local treatment of superficial ocular infections due to oxytetracycline and polymyxin-sensitive organisms, inc… (Official, 2026-02-12)
- side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- contraindications updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
- usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
FDA Products & Applications (Animal Drugs @ FDA)
Official sponsor/proprietary-name/application-status records linked by active ingredient.
| Product | Sponsor | Application | Status | Published |
|---|---|---|---|---|
|
Terramycin®
RX
Oxytetracycline Hydrochloride Polymyxin B Sulfate
Ointment
• Ophthalmic
|
Zoetis Inc. | NADA 8763 | Approved | Jul 1, 2024 |
|
Neomycin and Polymyxin B Sulfates, and Bacitracin Zinc Ophthalmic Ointment
RX
Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate
Ointment
• Ophthalmic
|
Domes Pharma S.A. | ANADA 200-553 | Approved | Oct 25, 2023 |
|
Anaprime® Ophthalmic Solution
RX
Flumethasone Neomycin Sulfate Polymyxin B Sulfate
Liquid
• Ophthalmic
|
Zoetis Inc. | NADA 38801 | Approved | Jun 1, 2016 |
|
Anaprime® Opthakote Ophthalmic
RX
Flumethasone Neomycin Sulfate Polymyxin B Sulfate
Liquid
• Ophthalmic
|
Zoetis Inc. | NADA 49725 | Approved | Jun 1, 2016 |
|
Bac-Neo-Poly Ophthalmic Ointment Vetropolycin Ophthalmic Ointment
RX
Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate
Ointment
• Ophthalmic
|
Dechra, Ltd. | NADA 65016 | Approved | Jun 1, 2016 |
|
Cortisporin Veterinary Ophthalmic Ointment
RX
Bacitracin Zinc Hydrocortisone Neomycin Sulfate Polymyxin B Sulfate
Ointment
• Ophthalmic
|
Intervet, Inc. | NADA 65476 | Approved | Jun 1, 2016 |
|
Forte Topical® Ointment
RX
Hydrocortisone Acetate Neomycin Sulfate Penicillin G Procaine Polymyxin B Sulfate
Ointment
• Topical
|
Zoetis Inc. | NADA 65119 | Approved | Jun 1, 2016 |
|
Mycitracin® Sterile Ophthalmic Ointment
OTC
Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate
Ointment
• Ophthalmic
|
Zoetis Inc. | NADA 65114 | Approved | Jun 1, 2016 |
|
Neosporin Ophthalmic Ointment
RX
Bacitracin Zinc Neomycin Sulfate Polymyxin B Sulfate
Ointment
• Ophthalmic
|
Intervet, Inc. | NADA 65485 | Approved | Jun 1, 2016 |
|
Optiprime® Opthakote Ophthalmic Solution
RX
Neomycin Sulfate Polymyxin B Sulfate
Liquid (Solution)
• Ophthalmic
|
Zoetis Inc. | NADA 49726 | Approved | Jun 1, 2016 |
|
Surolan®
RX
Miconazole Nitrate Polymyxin B Sulfate Prednisolone Acetate
Liquid (Suspension)
• Otic
|
Elanco US Inc. | NADA 141-298 | Approved | Jun 1, 2016 |
|
Toptic Ointment (15 g)
RX
Cephalonium Flumethasone Iodochlorhydroxyquin Piperocaine Hydrochloride Polymyxin B Sulfate
|
Elanco Animal Health, A Division of Eli Lilly & Co. | NADA 40123 | W | Jun 1, 2016 |
|
Vetropolycin HC Ophthalmic Ointment Bacitracin-Neomycin-Polymyxin with Hydrocortisone Acetate Ophthalmic Ointment
RX
Bacitracin Zinc Hydrocortisone Acetate Neomycin Sulfate Polymyxin B Sulfate
Ointment
• Ophthalmic
|
Dechra, Ltd. | NADA 65015 | Approved | Jun 1, 2016 |
Data source: FDA Animal Drugs @ FDA (public search export).
What It's For (FDA Label Highlights)
Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.
Composition / specifications
ointment contains oxytetracycline HCl equivalent to 5 mg of
oxytetracycline and 10,000 units of polymyxin B as the sulfate.
Terramycin® is indicated for the prophylaxis and local treatment of superficial ocular infections due to oxytetracycline and polymyxin-sensitive organisms, including infections due to streptococci, rickettsiae, E. coli, and A.aerogenes, such as conjunctivitis, keratitis, pink eye, corneal ulcer, blepharitis in dogs, cats, cattle, sheep, and horses; ocular infections due to secondary bacterial complications of distemper in dogs, and bacterial inflammatory conditions whichmay occur secondary to other infectious diseases in the above species.
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Composition / specifications
FDA page: Open in Animal Drugs @ FDA
Official Documents (FDA)
Direct links to FDA-hosted PDFs and SPL packages (when available).
- Terramycin® (ZIP)
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM457307.pdf
Summary
For the treatment of superficial bacterial infections of the eyelid and conjunctiva of dogs and cats when due to organisms susceptible to one or more of the antibiotics contained in the ointment.
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
- Forte Topical® Ointment (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
-
FOI UCM202424.pdf
Summary
For the treatment of canine otitis externa associated with susceptible strains of yeast ( Malassezia pachydermatis) and bacteria ( Staphylococcus pseudintermedius)
- Surolan® (ZIP)
FDA page: Open in Animal Drugs @ FDA
- Toptic Ointment (15 g) (ZIP)
FDA page: Open in Animal Drugs @ FDA
FDA page: Open in Animal Drugs @ FDA
Usage
Terramycin® is indicated for the prophylaxis and local treatment of superficial ocular infections due to oxytetracycline and polymyxin-sensitive organisms, including infections due to streptococci, rickettsiae, E. coli , and A.aerogenes , such as conjunctivitis, keratitis, pink eye, corneal ulcer, blepharitis in dogs, cats, cattle, sheep, and horses; ocular infections due to secondary bacterial complications of distemper in dogs, and bacterial inflammatory conditions whichmay occur secondary to other infectious diseases in the above species. Terramycin Ophthalmic Ointment with Polymyxin B Sulfate is indicated for the prophylaxis and local treatment of superficial ocular infections due to oxytetracycline and polymyxin-sensitive organisms, including infections due to streptococci, rickettsiae, E. coli , and A. aerogenes , such as conjunctivitis, keratitis, pink eye, corneal ulcer, blepharitis in dogs, cats, cattle, sheep, and horses; ocular infections due to secondary bacterial complications of distemper in dogs, and bacterial inflammatory conditions which may occur secondary to other infectious diseases in the above species. Treatment of the inflammation, edema, and secondary bacterial infections associated with topical ophthalmological conditions of the eye such as corneal injuries, incipient pannus, superficial keratitis, conjunctivitis, acute nongranulomatous anterior uveitis, kerato- conjunctivitis, and blepharitis.
Source: FDA Animal Drugs @ FDA • Reference
Contraindications
Federal law restricts this drug to use by or on the order of a licensed veterinarian. For use in dogs only. Shake drug thoroughly and clean lesion before using. If redness, irritation, or swelling persists or increases, discontinue use and reevaluate diagnosis. Federal law restricts this drug to use by or on the order of a licensed veterinarian. For otic use in dogs only. Do not administer orally. Do not use in dogs with known perforated tympanum. Do not use with drugs known to induce ototoxicity. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Side Effects
No approved side-effect narrative is linked yet.
openFDA reaction signals are available for Dog 56 and Cat 20 (view top reported reactions).
Top Reported Reactions (openFDA)
Aggregated reaction terms from FDA openFDA reports (not verified; does not prove causation).
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Adverse Event Case Summaries (openFDA)
These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.
Dog, ['Retriever - Golden', 'Poodle (unspecified)'], Male, 3 year, 31.75 kilogram • Drug: MSK, Suspension, Intraocular • Reactions: Squinting, Eye irritation, Medication error NOS • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055998
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 3.00 Year
- Weight: 31.750 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Intraocular
- Form: Suspension
Dog, Terrier - West Highland White, Male, 12 year, 9.52 kilogram • Drug: MSK, Suspension, Auricular (Otic), Dose: 1 dose per animal • Reactions: Deafness • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-055789
- Serious AE: Yes
- Treated For AE: No
- Sex: Male
- Age: 12.00 Year
- Weight: 9.520 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
- Form: Suspension
- Dose: 1 dose per animal
Dog, Pekingese, Male, 9 year, 3.17 kilogram • Drug: MSK, Suspension, Topical, Dose: 5 drops per animal, Frequency: 1 per day • Reactions: Unsteady walking (ataxia), Tremors, Head tremor, Loss of hearing • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-052802
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Male
- Age: 9.00 Year
- Weight: 3.170 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Topical
- Form: Suspension
- Dose: 5 drops per animal
- Frequency: 1 per day
Dog, Shepherd Dog - German, Male, 8.58 year, 46.62 kilogram • Drug: MSK, Suspension, Auricular (Otic), Dose: 5 drops per animal, Frequency: 12 per hour • Reactions: Vomiting, Loss of appetite • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-052712
- Serious AE: No
- Treated For AE: No
- Sex: Male
- Age: 8.58 Year
- Weight: 46.620 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
- Form: Suspension
- Dose: 5 drops per animal
- Frequency: 12 per hour
Dog, Maltese, Female, 11 year, 5.35 kilogram • Drug: MSK, Suspension, Auricular (Otic), Frequency: 12 per hour • Reactions: Loss of hearing • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-052344
- Serious AE: Yes
- Treated For AE: Yes
- Sex: Female
- Age: 11.00 Year
- Weight: 5.350 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
- Form: Suspension
- Frequency: 12 per hour
Cat, Domestic Shorthair, Male, 14 year, 6.58 kilogram • Drug: MSK, Suspension, Auricular (Otic) • Reactions: Unsteady walking (ataxia), Vocalisation • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2025-US-050900
- Serious AE: No
- Treated For AE: Yes
- Sex: Male
- Age: 14.00 Year
- Weight: 6.580 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
- Form: Suspension
Cat, Domestic Shorthair, Female, 18 year, 3.68 kilogram • Drug: MSK, Suspension, Auricular (Otic), Dose: 5 drops per animal, Frequency: 12 per hour • Reactions: Mewing, Loss of hearing • Outcome: Ongoing
- Report ID: USA-USFDACVM-2025-US-031666
- Serious AE: Yes
- Treated For AE: No
- Sex: Female
- Age: 18.00 Year
- Weight: 3.680 Kilogram
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
- Form: Suspension
- Dose: 5 drops per animal
- Frequency: 12 per hour
Cat, Cat (unknown), Unknown • Drug: MSK, Suspension, Auricular (Otic), Dose: 1 dose per animal • Reactions: Unclassifiable adverse event • Outcome: Outcome Unknown
- Report ID: USA-USFDACVM-2024-US-052436
- Serious AE: No
- Treated For AE: No
- Sex: Unknown
- Case-reported brand: MSK
- Case-reported manufacturer: MSK
- Route: Auricular (Otic)
- Form: Suspension
- Dose: 1 dose per animal
Data source: FDA openFDA Animal & Veterinary adverse event reports.
Overdose Information
No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.
Storage & Handling
No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.
Share Your Thoughts
Let others know your experience or advice regarding this medication.
This medication has not been reviewed by a veterinarian yet.